Blog

The New York Times Just Exposed How a $1.8 Billion Peptide Company Misled Hundreds of Thousands of Customers

The NYT called MEDVi an AI success story. The FDA had already warned them for misleading customers. Here's what the profile missed — and what it means for anyone buying in this space.